EUVIMEDEUVIMED entdecken
Crossref

Motoneuron excitability in Parkinson’s disease: effects of dopaminergic medication

Parisa Alaei, Gregory E P Pearcey iD, Daryl J Wile iD, Aleš Holobar iD, Jennifer M Jakobi iD

Journal of Neurophysiology · 2026

DOI: 10.1152/jn.00614.2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurophysiology, 2026. Verfasst von Parisa Alaei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health and Social Development, University of British Columbia Okanagan, Kelowna, British Columbia, Canada. Hauptthemen laut MEDLINE: Parkinson Disease, Motor Neurons, Dopamine Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Natural Sciences and Engineering Research Council of Canada (NSERC), European Union's Horizon Europe Research and Innovation Program, The Slovenian Research and Innovation Agency (ARRS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study provides new evidence that motoneuron excitability is consistently elevated in people with Parkinson’s disease (PD) independent of dopaminergic medication. People with PD showed higher initial discharge rates, lower recruitment thresholds, and greater indicators of persistent inward currents than controls, pointing to lasting spinal adaptations driven by chronic monoaminergic deficits. The persistence of these abnormalities despite dopamine replacement therapy indicates that chronic monoaminergic depletion produces enduring plasticity within the spinal circuits that persists despite dopamine replacement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseMotor NeuronsDopamine AgentsHumansFemaleAgedMaleMiddle AgedMuscle, SkeletalIsometric ContractionElectromyography

Stichwörter der Autor:innen

HDsEMGbiceps brachiimonoaminesneuromodulationpersistent inward currents

Substanzen

Dopamine Agents

Autor:innen und Institutionen

  • Faculty of Health and Social Development, University of British Columbia Okanagan, Kelowna, British Columbia, Canada.
  • Healthy Exercise and Aging Laboratory, Aging in Place Research Cluster, University of British Columbia Okanagan, Kelowna, British Columbia, Canada.
  • School of Human Kinetics and Recreation, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.
  • Centre for Chronic Disease Prevention and Management, University of British Columbia Okanagan, Kelowna, British Columbia, Canada.
  • Faculty of Electrical Engineering and Computer Science, University of Maribor, Maribor, Slovenia.

ORCID-Profile: Gregory E P Pearcey, Daryl J Wile, Aleš Holobar, Jennifer M Jakobi

Förderung

  • Natural Sciences and Engineering Research Council of Canada (NSERC)
  • European Union's Horizon Europe Research and Innovation Program
  • The Slovenian Research and Innovation Agency (ARRS)
  • European Union’s Horizon Europe Research and Innovation Program

Zitieren

APA

Alaei, P., Pearcey, G. E. P., Wile, D. J., Holobar, A., & Jakobi, J. M. (2026). Motoneuron excitability in Parkinson’s disease: effects of dopaminergic medication. Journal of Neurophysiology. https://doi.org/10.1152/jn.00614.2025

Vancouver

Alaei P, Pearcey GEP, Wile DJ, Holobar A, Jakobi JM. Motoneuron excitability in Parkinson’s disease: effects of dopaminergic medication. Journal of Neurophysiology. 2026. doi:10.1152/jn.00614.2025

BibTeX
@article{Alaei2026,
  author = {Alaei, Parisa and Pearcey, Gregory E P and Wile, Daryl J and Holobar, Aleš and Jakobi, Jennifer M},
  title = {Motoneuron excitability in Parkinson’s disease: effects of dopaminergic medication},
  journal = {Journal of Neurophysiology},
  year = {2026},
  doi = {10.1152/jn.00614.2025}
}
Kostenlos starten →